Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
133.00
+2.00 (1.53%)
Apr 2, 2025, 1:30 PM CST

Alar Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
8,8849,45211,9426,5552,6082,793
Upgrade
Market Cap Growth
-20.85%-20.85%82.17%151.37%-6.63%-
Upgrade
Enterprise Value
6,4547,02811,3266,0462,0532,171
Upgrade
Last Close Price
133.00141.50208.35114.3745.5048.73
Upgrade
PE Ratio
488.96520.2131.21---
Upgrade
PS Ratio
1624.931624.9325.458193.75-4655.00
Upgrade
PB Ratio
3.573.7913.3112.744.884.67
Upgrade
P/TBV Ratio
3.793.7913.3112.744.884.67
Upgrade
P/FCF Ratio
-30.06---
Upgrade
P/OCF Ratio
-29.59---
Upgrade
EV/Sales Ratio
1208.221208.2224.147557.22-3617.60
Upgrade
EV/EBITDA Ratio
-29.22---
Upgrade
EV/EBIT Ratio
-29.38---
Upgrade
EV/FCF Ratio
-92.41-28.51---
Upgrade
Debt / Equity Ratio
000.000.010.000.00
Upgrade
Debt / EBITDA Ratio
--0.00---
Upgrade
Debt / FCF Ratio
--0.00---
Upgrade
Asset Turnover
0.000.000.630.00-0.00
Upgrade
Quick Ratio
44.1444.1411.9890.70116.51135.92
Upgrade
Current Ratio
44.3344.3312.0892.66118.67143.31
Upgrade
Return on Equity (ROE)
1.07%1.07%54.21%-3.79%-11.34%-36.17%
Upgrade
Return on Assets (ROA)
-2.41%-2.41%32.22%-5.47%-10.20%-26.68%
Upgrade
Return on Capital (ROIC)
-2.50%-2.50%34.04%-5.53%-10.27%-26.90%
Upgrade
Return on Capital Employed (ROCE)
--42.90%---
Upgrade
Earnings Yield
0.20%0.19%3.20%-0.30%-2.46%-5.11%
Upgrade
FCF Yield
-0.79%-0.74%3.33%-0.52%-2.49%-5.10%
Upgrade
Dividend Yield
0.19%0.18%0.72%---
Upgrade
Payout Ratio
551.46%551.46%----
Upgrade
Buyback Yield / Dilution
-16.08%-16.08%-0.09%--14.21%-42.59%
Upgrade
Total Shareholder Return
-15.89%-15.90%0.63%--14.21%-42.59%
Upgrade
Updated Mar 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.